<p>Hendley &amp; Co. Inc. 在最近向证券交易委员会（SEC）提交的 13F 表格中披露，在第二季度将其在史赛克公司的股份提高了 60.3%。该公司在季度内额外购买了 5,274 股后，持有该医疗科技公司 14,018 股股票。史赛克约占 Hendley &amp; Co. Inc. 投资组合的 1.9%，使其成为该公司第 18 大持仓。根据 Hendley &amp; Co. Inc. 最近向证券交易委员会（SEC）提交的文件，其在史赛克的持股价值为 5,546,000 美元。</p>
<ul>
<li>如果你只能持有 3 项投资一辈子，请考虑这些</li>
</ul>
<p>其他对冲基金最近也增加或减少了在该公司的股份。Mogy Joel R Investment Counsel Inc. 在第一季度将其在史赛克的持仓提高了 3.4%。Mogy Joel R Investment Counsel Inc. 现在持有 98,216 股该医疗科技公司的股票，价值 36,561,000 美元，在此期间又购买了 3,218 股。Ferguson Wellman Capital Management Inc. 在第一季度将其在史赛克的持仓提高了 1.9%。Ferguson Wellman Capital Management Inc. 现在持有 174,871 股该医疗科技公司的股票，价值 65,096,000 美元，在此期间又购买了 3,341 股。Harbor Capital Advisors Inc. 在第一季度购买了价值约 1,840,000 美元的史赛克新股份。Mar Vista Investment Partners LLC 在第一季度将其在史赛克的股份增加了 10.2%。Mar Vista Investment Partners LLC 现在持有 90,187 股该医疗科技公司的股票，价值 33,572,000 美元，在上个季度又收购了 8,353 股。最后，联合服务汽车协会在第一季度购买了价值约 2,857,000 美元的史赛克新股份。77.09% 的股票由对冲基金和其他机构投资者持有。</p>
<h2>史赛克股票上涨 0.8%</h2>
<p>史赛克股票周三开盘价为 369.14 美元。该公司的速动比率为 1.06，流动比率为 1.78，债务与股本比率为 0.70。该公司的市值为 1411.2 亿美元，市盈率为 48.89，市盈增长比率为 2.64，贝塔值为 0.94。史赛克公司的 52 周低点为 329.16 美元，52 周高点为 406.19 美元。该公司的 50 日移动平均价格为 381.50 美元，200 日移动平均价格为 378.86 美元。</p>
<ul>
<li>3 只帮助将人工智能引入医疗保健的股票</li>
</ul>
<p>史赛克（NYSE:SYK - 获取免费报告）最近在 7 月 31 日（星期四）公布了季度财报。该医疗科技公司报告季度每股收益为 3.13 美元，超出市场共识预期的 3.07 美元，超出 0.06 美元。该公司在季度内的收入为 60.2 亿美元，而分析师预期为 59.2 亿美元。史赛克的股本回报率为 23.94%，净利润率为 12.25%。与去年同期相比，史赛克的季度收入增长了 11.1%。在去年同期，该公司每股收益为 2.81 美元。史赛克已将其 2025 财年的指导目标设定为 13.400-13.600 每股收益。平均而言，卖方分析师预测史赛克公司本财年的每股收益为 13.47 美元。</p>
<h2>史赛克宣布分红</h2>
<p>该公司最近还宣布了季度分红，将于 10 月 31 日（星期五）支付。9 月 30 日（星期二）登记的股东将获得 0.84 美元的分红。这相当于年化 3.36 美元的分红，收益率为 0.9%。除息日为 9 月 30 日（星期二）。史赛克的派息比率目前为 44.50%。</p>
<h2>分析师设定新目标价</h2>
<ul>
<li>波士顿科学：为什么这家医疗科技巨头没有放慢脚步</li>
</ul>
<p>多家券商最近对 SYK 发布了报告。BTIG Research 在 7 月 14 日（星期一）的研究报告中重申了对史赛克股票的 “买入” 评级。Redburn Partners 在 9 月 18 日（星期四）的研究报告中将史赛克的目标价设定为 420.00 美元。Weiss Ratings 在 9 月 27 日（星期六）的研究报告中重申了对史赛克股票的 “买入（b-）” 评级。富国银行在 8 月 1 日（星期五）的研究报告中将史赛克的目标价从 435.00 美元上调至 445.00 美元，并给予该股票 “超配” 评级。最后，Rothschild Redb 在 9 月 18 日（星期四）的研究报告中将史赛克的评级上调至 “持有”。十五位投资分析师对该股票给予了买入评级，六位分析师对该公司给予了持有评级。根据 MarketBeat.com 的数据，该公司的共识评级为 “适度买入”，平均目标价为 430.10 美元。</p>
<p><strong>阅读我们关于史赛克的最新研究报告</strong></p>
<h2>内部买卖</h2>
<p>在其他史赛克新闻中，董事 Ronda E. Stryker 于 8 月 6 日（星期三）出售了 200,000 股史赛克股票，交易发生在该股票的平均价格为 376.45 美元，总价值为 75,290,000.00 美元。交易完成后，该董事直接持有该公司 3,222,108 股股票，价值 1,212,962,556.60 美元。此次交易使其持股减少了 5.84%。该出售在向 SEC 的法律文件中披露，文件可在此链接查看。此外，内部人士 Viju Menon 于 8 月 25 日（星期一）出售了 500 股史赛克股票，交易发生在该股票的平均价格为 390.61 美元，总价值为 195,305.00 美元。交易完成后，该内部人士持有该公司约 12,511 股股票，价值约 4,886,921.71 美元。该出售的披露可在此处找到。内部人士持有该公司 5.20% 的股票。</p>
<h2>史赛克简介</h2>
<p>（免费报告）</p>
<p>史赛克公司是一家医疗技术公司。该公司通过两个部门运营，分别是医疗外科和神经技术，以及骨科和脊柱。骨科和脊柱部门提供用于全关节置换的植入物，如髋关节、膝关节和肩关节，以及创伤和四肢手术。</p>
<h2>精选故事</h2>
<ul>
<li>五只我们认为比史赛克更好的股票</li>
<li>如何利用分析师评级进行交易</li>
<li>EA 550 亿美元交易引发游戏行业震荡</li>
<li>三只小盘股具有巨大的回报潜力</li>
<li>这些是第三季度盈利增长的三大热门行业</li>
<li>股票交易术语 - 每位投资者需要了解的股票术语</li>
<li>AMD 可能会在此基础上翻倍——得益于其与 OpenAI 的重磅交易</li>
</ul>
<p><strong>想看看其他对 SYK 持有的对冲基金吗？</strong> 请访问 HoldingsChannel.com，获取史赛克公司（NYSE:SYK - 免费报告）的最新 13F 文件和内部交易信息。</p>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPVNZSw?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPVNZSw"/></p>
<p><em>此即时新闻提醒由叙事科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快和最准确的报道。此故事在发布前已由 MarketBeat 的编辑团队审核。如对该故事有任何问题或意见，请发送至 contact@marketbeat.com。</em></p>
<h2>你现在应该投资 1,000 美元在史赛克吗？</h2>
<p>在考虑史赛克之前，你需要听听这个。</p>
<p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄建议客户在更广泛的市场注意到之前购买的股票……而史赛克并不在名单上。</p>
<p>虽然史赛克目前在分析师中获得了中等买入评级，但顶级分析师认为这五只股票更值得购买。</p>
<p>在这里查看这五只股票</p>

史赛克

<p>Hendley & Co. Inc. 在第二季度将其在史赛克（NYSE:SYK）的持股增加了 60.3%，目前持有 14,018 股，价值为 555 万美元。其他对冲基金也调整了他们的持仓，机构投资者持有该股票的比例为 77.09%。史赛克的股票开盘价为 369.14 美元，市值为 1411.2 亿美元。该公司报告第二季度每股收益为 3.13 美元，超出预期，并宣布季度股息为 0.84 美元。分析师维持 “适度买入” 的共识，平均目标价为 430.10 美元</p>

<p>Hendley &amp; Co. Inc. raised its stake in Stryker Corporation (NYSE:SYK - Free Report) by 60.3% during the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 14,018 shares of the medical technology company's stock after purchasing an additional 5,274 shares during the quarter. Stryker comprises about 1.9% of Hendley &amp; Co. Inc.'s investment portfolio, making the stock its 18th biggest position. Hendley &amp; Co. Inc.'s holdings in Stryker were worth $5,546,000 as of its most recent filing with the Securities and Exchange Commission (SEC).</p>
<div class="lb-trans"><p>Hendley &amp; Co. Inc. 在最近向证券交易委员会（SEC）提交的 13F 表格中披露，在第二季度将其在史赛克公司的股份提高了 60.3%。该公司在季度内额外购买了 5,274 股后，持有该医疗科技公司 14,018 股股票。史赛克约占 Hendley &amp; Co. Inc. 投资组合的 1.9%，使其成为该公司第 18 大持仓。根据 Hendley &amp; Co. Inc. 最近向证券交易委员会（SEC）提交的文件，其在史赛克的持股价值为 5,546,000 美元。</p>
</div><ul>
<li>If You Could Only Hold 3 Investments for Life, Consider These</li>
</ul>
<div class="lb-trans"><ul>
<li>如果你只能持有 3 项投资一辈子，请考虑这些</li>
</ul>
</div><p>Other hedge funds also recently added to or reduced their stakes in the company. Mogy Joel R Investment Counsel Inc. raised its position in Stryker by 3.4% in the first quarter. Mogy Joel R Investment Counsel Inc. now owns 98,216 shares of the medical technology company's stock valued at $36,561,000 after purchasing an additional 3,218 shares during the period. Ferguson Wellman Capital Management Inc. raised its position in Stryker by 1.9% in the first quarter. Ferguson Wellman Capital Management Inc. now owns 174,871 shares of the medical technology company's stock valued at $65,096,000 after purchasing an additional 3,341 shares during the period. Harbor Capital Advisors Inc. purchased a new position in Stryker in the first quarter valued at about $1,840,000. Mar Vista Investment Partners LLC increased its position in shares of Stryker by 10.2% during the first quarter. Mar Vista Investment Partners LLC now owns 90,187 shares of the medical technology company's stock worth $33,572,000 after acquiring an additional 8,353 shares during the last quarter. Finally, United Services Automobile Association purchased a new stake in shares of Stryker during the first quarter worth about $2,857,000. 77.09% of the stock is owned by hedge funds and other institutional investors.</p>
<div class="lb-trans"><p>其他对冲基金最近也增加或减少了在该公司的股份。Mogy Joel R Investment Counsel Inc. 在第一季度将其在史赛克的持仓提高了 3.4%。Mogy Joel R Investment Counsel Inc. 现在持有 98,216 股该医疗科技公司的股票，价值 36,561,000 美元，在此期间又购买了 3,218 股。Ferguson Wellman Capital Management Inc. 在第一季度将其在史赛克的持仓提高了 1.9%。Ferguson Wellman Capital Management Inc. 现在持有 174,871 股该医疗科技公司的股票，价值 65,096,000 美元，在此期间又购买了 3,341 股。Harbor Capital Advisors Inc. 在第一季度购买了价值约 1,840,000 美元的史赛克新股份。Mar Vista Investment Partners LLC 在第一季度将其在史赛克的股份增加了 10.2%。Mar Vista Investment Partners LLC 现在持有 90,187 股该医疗科技公司的股票，价值 33,572,000 美元，在上个季度又收购了 8,353 股。最后，联合服务汽车协会在第一季度购买了价值约 2,857,000 美元的史赛克新股份。77.09% 的股票由对冲基金和其他机构投资者持有。</p>
</div><h2>Stryker Stock Up 0.8%</h2>
<div class="lb-trans"><h2>史赛克股票上涨 0.8%</h2>
</div><p>Shares of Stryker stock opened at $369.14 on Wednesday. The company has a quick ratio of 1.06, a current ratio of 1.78 and a debt-to-equity ratio of 0.70. The firm has a market cap of $141.12 billion, a P/E ratio of 48.89, a P/E/G ratio of 2.64 and a beta of 0.94. Stryker Corporation has a fifty-two week low of $329.16 and a fifty-two week high of $406.19. The business has a 50-day moving average price of $381.50 and a 200 day moving average price of $378.86.</p>
<div class="lb-trans"><p>史赛克股票周三开盘价为 369.14 美元。该公司的速动比率为 1.06，流动比率为 1.78，债务与股本比率为 0.70。该公司的市值为 1411.2 亿美元，市盈率为 48.89，市盈增长比率为 2.64，贝塔值为 0.94。史赛克公司的 52 周低点为 329.16 美元，52 周高点为 406.19 美元。该公司的 50 日移动平均价格为 381.50 美元，200 日移动平均价格为 378.86 美元。</p>
</div><ul>
<li>3 Stocks Helping to Bring AI to Healthcare</li>
</ul>
<div class="lb-trans"><ul>
<li>3 只帮助将人工智能引入医疗保健的股票</li>
</ul>
</div><p>Stryker (NYSE:SYK - Get Free Report) last announced its quarterly earnings data on Thursday, July 31st. The medical technology company reported $3.13 earnings per share for the quarter, beating the consensus estimate of $3.07 by $0.06. The firm had revenue of $6.02 billion during the quarter, compared to analyst estimates of $5.92 billion. Stryker had a return on equity of 23.94% and a net margin of 12.25%.Stryker's quarterly revenue was up 11.1% on a year-over-year basis. During the same period in the previous year, the company earned $2.81 earnings per share. Stryker has set its FY 2025 guidance at 13.400-13.600 EPS. On average, sell-side analysts forecast that Stryker Corporation will post 13.47 earnings per share for the current fiscal year.</p>
<div class="lb-trans"><p>史赛克（NYSE:SYK - 获取免费报告）最近在 7 月 31 日（星期四）公布了季度财报。该医疗科技公司报告季度每股收益为 3.13 美元，超出市场共识预期的 3.07 美元，超出 0.06 美元。该公司在季度内的收入为 60.2 亿美元，而分析师预期为 59.2 亿美元。史赛克的股本回报率为 23.94%，净利润率为 12.25%。与去年同期相比，史赛克的季度收入增长了 11.1%。在去年同期，该公司每股收益为 2.81 美元。史赛克已将其 2025 财年的指导目标设定为 13.400-13.600 每股收益。平均而言，卖方分析师预测史赛克公司本财年的每股收益为 13.47 美元。</p>
</div><h2>Stryker Announces Dividend</h2>
<div class="lb-trans"><h2>史赛克宣布分红</h2>
</div><p>The business also recently announced a quarterly dividend, which will be paid on Friday, October 31st. Shareholders of record on Tuesday, September 30th will be paid a $0.84 dividend. This represents a $3.36 dividend on an annualized basis and a yield of 0.9%. The ex-dividend date is Tuesday, September 30th. Stryker's payout ratio is presently 44.50%.</p>
<div class="lb-trans"><p>该公司最近还宣布了季度分红，将于 10 月 31 日（星期五）支付。9 月 30 日（星期二）登记的股东将获得 0.84 美元的分红。这相当于年化 3.36 美元的分红，收益率为 0.9%。除息日为 9 月 30 日（星期二）。史赛克的派息比率目前为 44.50%。</p>
</div><h2>Analysts Set New Price Targets</h2>
<div class="lb-trans"><h2>分析师设定新目标价</h2>
</div><ul>
<li>Boston Scientific: Why This MedTech Giant Isn’t Slowing Down</li>
</ul>
<div class="lb-trans"><ul>
<li>波士顿科学：为什么这家医疗科技巨头没有放慢脚步</li>
</ul>
</div><p>A number of brokerages have recently issued reports on SYK. BTIG Research reaffirmed a &#34;buy&#34; rating on shares of Stryker in a research report on Monday, July 14th. Redburn Partners set a $420.00 target price on Stryker in a research report on Thursday, September 18th. Weiss Ratings reaffirmed a &#34;buy (b-)&#34; rating on shares of Stryker in a research report on Saturday, September 27th. Wells Fargo &amp; Company lifted their target price on Stryker from $435.00 to $445.00 and gave the stock an &#34;overweight&#34; rating in a research report on Friday, August 1st. Finally, Rothschild Redb raised Stryker to a &#34;hold&#34; rating in a research report on Thursday, September 18th. Fifteen investment analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the company. According to data from MarketBeat.com, the company currently has a consensus rating of &#34;Moderate Buy&#34; and an average price target of $430.10.</p>
<div class="lb-trans"><p>多家券商最近对 SYK 发布了报告。BTIG Research 在 7 月 14 日（星期一）的研究报告中重申了对史赛克股票的 “买入” 评级。Redburn Partners 在 9 月 18 日（星期四）的研究报告中将史赛克的目标价设定为 420.00 美元。Weiss Ratings 在 9 月 27 日（星期六）的研究报告中重申了对史赛克股票的 “买入（b-）” 评级。富国银行在 8 月 1 日（星期五）的研究报告中将史赛克的目标价从 435.00 美元上调至 445.00 美元，并给予该股票 “超配” 评级。最后，Rothschild Redb 在 9 月 18 日（星期四）的研究报告中将史赛克的评级上调至 “持有”。十五位投资分析师对该股票给予了买入评级，六位分析师对该公司给予了持有评级。根据 MarketBeat.com 的数据，该公司的共识评级为 “适度买入”，平均目标价为 430.10 美元。</p>
</div><p><strong>Read Our Latest Research Report on Stryker</strong></p>
<div class="lb-trans"><p><strong>阅读我们关于史赛克的最新研究报告</strong></p>
</div><h2>Insider Buying and Selling</h2>
<div class="lb-trans"><h2>内部买卖</h2>
</div><p>In other Stryker news, Director Ronda E. Stryker sold 200,000 shares of Stryker stock in a transaction that occurred on Wednesday, August 6th. The stock was sold at an average price of $376.45, for a total value of $75,290,000.00. Following the completion of the transaction, the director directly owned 3,222,108 shares in the company, valued at $1,212,962,556.60. The trade was a 5.84% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this link. Also, insider Viju Menon sold 500 shares of Stryker stock in a transaction that occurred on Monday, August 25th. The shares were sold at an average price of $390.61, for a total value of $195,305.00. Following the completion of the transaction, the insider owned 12,511 shares of the company's stock, valued at approximately $4,886,921.71. The trade was a 3.84% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders own 5.20% of the company's stock.</p>
<div class="lb-trans"><p>在其他史赛克新闻中，董事 Ronda E. Stryker 于 8 月 6 日（星期三）出售了 200,000 股史赛克股票，交易发生在该股票的平均价格为 376.45 美元，总价值为 75,290,000.00 美元。交易完成后，该董事直接持有该公司 3,222,108 股股票，价值 1,212,962,556.60 美元。此次交易使其持股减少了 5.84%。该出售在向 SEC 的法律文件中披露，文件可在此链接查看。此外，内部人士 Viju Menon 于 8 月 25 日（星期一）出售了 500 股史赛克股票，交易发生在该股票的平均价格为 390.61 美元，总价值为 195,305.00 美元。交易完成后，该内部人士持有该公司约 12,511 股股票，价值约 4,886,921.71 美元。该出售的披露可在此处找到。内部人士持有该公司 5.20% 的股票。</p>
</div><h2>Stryker Profile</h2>
<div class="lb-trans"><h2>史赛克简介</h2>
</div><p>(Free Report)</p>
<div class="lb-trans"><p>（免费报告）</p>
</div><p>Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries.</p>
<div class="lb-trans"><p>史赛克公司是一家医疗技术公司。该公司通过两个部门运营，分别是医疗外科和神经技术，以及骨科和脊柱。骨科和脊柱部门提供用于全关节置换的植入物，如髋关节、膝关节和肩关节，以及创伤和四肢手术。</p>
</div><h2>Featured Stories</h2>
<div class="lb-trans"><h2>精选故事</h2>
</div><ul>
<li>Five stocks we like better than Stryker</li>
<li>How to trade using analyst ratings</li>
<li>EA’s $55 Billion Deal Spurs a Shake-Up in the Gaming Sector</li>
<li>3 Small Caps With Big Return Potential</li>
<li>These Are the 3 Hottest Sectors for Q3 Earnings Growth</li>
<li>Stock Trading Terms - Stock Terms Every Investor Needs to Know</li>
<li>AMD Could Double From Here—Thanks to Its Blockbuster OpenAI Deal</li>
</ul>
<div class="lb-trans"><ul>
<li>五只我们认为比史赛克更好的股票</li>
<li>如何利用分析师评级进行交易</li>
<li>EA 550 亿美元交易引发游戏行业震荡</li>
<li>三只小盘股具有巨大的回报潜力</li>
<li>这些是第三季度盈利增长的三大热门行业</li>
<li>股票交易术语 - 每位投资者需要了解的股票术语</li>
<li>AMD 可能会在此基础上翻倍——得益于其与 OpenAI 的重磅交易</li>
</ul>
</div><p><strong>Want to see what other hedge funds are holding SYK?</strong> Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Stryker Corporation (NYSE:SYK - Free Report).</p>
<div class="lb-trans"><p><strong>想看看其他对 SYK 持有的对冲基金吗？</strong> 请访问 HoldingsChannel.com，获取史赛克公司（NYSE:SYK - 免费报告）的最新 13F 文件和内部交易信息。</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPVNZSw" alt="" original-src="https://www.marketbeat.com/scripts/SECFilingChart.ashx?Prefix=NYSE&amp;Symbol=SYK"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻提醒由叙事科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快和最准确的报道。此故事在发布前已由 MarketBeat 的编辑团队审核。如对该故事有任何问题或意见，请发送至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in Stryker Right Now?</h2>
<div class="lb-trans"><h2>你现在应该投资 1,000 美元在史赛克吗？</h2>
</div><p>Before you consider Stryker, you'll want to hear this.</p>
<div class="lb-trans"><p>在考虑史赛克之前，你需要听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Stryker wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄建议客户在更广泛的市场注意到之前购买的股票……而史赛克并不在名单上。</p>
</div><p>While Stryker currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>虽然史赛克目前在分析师中获得了中等买入评级，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在这里查看这五只股票</p>
</div>

Hendley & Co. Inc. 购买了史赛克公司 $SYK 的股票